Skip to main content
Log in

Melanoma × macrophage hybrids with enhanced metastatic potential

  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Abstract

Studies were conducted on the hypothesis that melanoma metastasis might be initiated through the gener-ation of hybrids comprised of cells of the primary tumor and tumor-infiltrating leukocytes. Fusion hybrids were generated in vitro between weakly metastatic Cloudman S91 mouse melanoma cells and normal mouse or human macrophages. Hybrids were implanted s.c. in the tail and mice were monitored for metastases. Controls included parental S91 cells, autologous S91 × S91 hybrids, and B16F10 melanoma cells. Of 35 hybrids tested, most were more aggressive than the parental melanoma cells, producing metastases sooner and in more mice. A striking characteristic was heterogeneity amongst hybrids, with some lines producing no metastases and others producing metastases in up to 80% of mice. With few exceptions, hybrids with the highest metastatic potential also had the highest basal melanin content whereas those with the lowest metastatic potential were basally amelanotic, as were t he parental melanoma cells. A spontaneous in vivo supermelanotic hybrid between an S91 tumor cell and DBA/2J host cell was one of the most metastatic lines. Hybrids with the highest metastatic potential also exhibited markedly higher chemotaxis to fibroblast-conditioned media. Histologically, the metastatic hybrids demonstrated vascular invasion and spread to distant organs similar to that of metastatic melanomas in mice and humans. Thus previous findings of enhanced metastasis in leukocyte × lymphoma hybrids can now be extended to include leukocyte × melanoma hybrids. Whether such hybridization is a natural cause of metastasis in vivo remains to be determined; however the fusion hybrids with genetically-matched parents described herein so closely resembled naturally- occurring metastatic melanoma cells that they could serve as useful new models for studies of this complex and deadly phenomenon. © Rapid Science Ltd.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Herrlich P, Zoller M, Pals ST and Ponta H, 1993, CD44 splice variants: metastases meet lymphocytes. Immunol Today, 14, 395-9.

    Google Scholar 

  2. Ruoslahti E, 1996, How cancer spreads. Sci Amer, 275, 72-7.

    Google Scholar 

  3. Buck CA, 1995, Adhesion mechanisms controlling cell-cell and cell-matrix interactions during the metastatic process. In: Mendelsohn J, Howley PM, Israel MA and Liotta LA, eds. The Molecular Basis of Cancer.Philadelphia: W.B. Saunders Co., pp. 172-205.

    Google Scholar 

  4. Aichel O, 1911, In: Roux W, ed. “Vorträge und Aufsätze über Entvickelungsmechanik Der Organismen”. Leipzig, Germany: Wilhelm Engelmann, pp. 1-115.

    Google Scholar 

  5. Mekler LB, 1971, Hybridization of transformed cells with lymphocytes as one of the probable courses of the progression leading to the development of metastatic malignant cells. (translation) Vestnick Akademii Meditsinskikh Nauk SSSR, 26, 80-9.

    Google Scholar 

  6. Warner TFCS, 1975, Cell hybridization: An explanation for the phenotypic diversity of certain tumours. Med Hypoth, 1, 51-7.

    Google Scholar 

  7. Fidler IJ, 1973, Selection of successive tumour lines for metastasis. Nature New Biol, 242, 148-9.

    Google Scholar 

  8. Fidler IJ and Kripke ML, 1977, Metastasis results from preexisting variant cells within a malignant tumor. Science, 197, 893-5.

    Google Scholar 

  9. Fidler IJ and Hart IR, 1982, Biological diversity in metastatic neoplasms: origins and implications. Science, 217, 998-1003.

    Google Scholar 

  10. Kerbel RS, 1989, Towards an understanding of the molecular basis of the metastatic phenotype. Invasion Metastasis, 9, 329-37.

    Google Scholar 

  11. Fidler J and Radinsky R, 1990, Genetic control of cancer metastasis. J Natl Cancer Inst USA, 82, 166-8.

    Google Scholar 

  12. Nicolson GL, 1991, Gene expression, cellular diversification and tumor progression to the metastatic phenotype. BioEssays, 13, 337-42.

    Google Scholar 

  13. Lu C, Vickers MF and Kerbel RS, 1992, Interleukin 6: a fibroblast-derived growth inhibitor of human melanoma cells from early but not advanced stages of tumor progression. Proc Natl Acad Sci USA, 89, 9215-19.

    Google Scholar 

  14. Rak JW and Kerbel RS, 1993, Growth advantage (“clonal dominance”) of metastatically competent tumor cell variants expressed under selective two-and three-dimensional tissue culture conditions. In Vitro Cell Dev Biol Ani, 29A, 742-8.

    Google Scholar 

  15. Lu C and Kerbel RS, 1993, Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression. J Cell Biol, 120, 1281-8.

    Google Scholar 

  16. Weinstein IB, Carothers AM, Santella RM and Perera FP, 1995, Molecular mechanisms of mutagenesis and multistage carcinogenesis. In: Mendelsohn J, Howley PM, Israel MA and Liotta LA, eds. The Molecular Basis of Cancer. Philadelphia: W.B. Saunders Co., pp. 59-85.

    Google Scholar 

  17. Reynolds TY, Rockwell S and Glazer PM, 1996, Genetic instability induced by the tumor microenvironment. Cancer Res, 56, 5754-7.

    Google Scholar 

  18. Margulis L and Fester R, eds, 1991, Symbiosis as a Source of Evolutionary Innovation. Cambridge, MA: The MIT Press, 454 pp.

    Google Scholar 

  19. Margulis L and Sagan D, 1991, Microcosmos. Four Billion Years of Evolution from Our Microbial Ancestors. New York: Simon and Schuster, 281 pp.

    Google Scholar 

  20. Gauwerky CE and Croce CM, 1995, Molecular genetics and cytogenetics of hematopoietic malignancies. In: Mendelsohn J, Howley PM, Israel MA and Liotta LA, eds. The Molecular Basis of Cancer. Philadelphia, PA: W.B. Saunders Co, pp. 18-37.

    Google Scholar 

  21. Weiner F, Klein G and Harris H, 1974, The analysis of malignancy by cell fusion. J Cell Sci, 15, 177-83.

    Google Scholar 

  22. Stanbridge EJ, 1976, Suppression of malignancy in human cells. Nature, 260, 17-20.

    Google Scholar 

  23. Sidebottom E, 1980, The analysis of malignancy by cell fusion. In Vitro, 16, 77-86.

    Google Scholar 

  24. Ramshaw IA, Carlsen S, Wang H and Badenoch-Jones P, 1983, The use of cell fusion to analyse factors involved in tumour cell metastasis. Int J Cancer, 32, 471-8.

    Google Scholar 

  25. Harris H, 1988, The analysis of malignancy by cell fusion: the position in 1988. Cancer Res, 48, 3302-06.

    Google Scholar 

  26. Weinberg AS, 1991, Tumor suppressor genes. Science, 254, 1138-46.

    Google Scholar 

  27. Levine AJ, 1995, Tumor suppressor genes. In: Mendelsohn J, Howley PM, Israel MA and Liotta LA, eds. The Molecular Basis of Cancer. Philadelphia, PA: W.B. Saunders Co., pp. 86-104.

    Google Scholar 

  28. Scaletta LJ and Ephrussi, 1965, Hybridization of normal and neoplastic cells in vitro. Nature, 205, 1169.

    Google Scholar 

  29. Defendi V, Ephrussi B, Koprowski H and Yoshida MC, 1967, Properties of hybrids between polyoma-Transformed and normal mouse cells. Proc Natl Acad Sci USA, 57, 299-305.

    Google Scholar 

  30. Jonasson J, Povey S and Harris H, 1977, The analysis of malignancy by cell fusion. VII. Cytogenetic analysis of hybrids between malignant diploid cells and of tumours derived from them. J Cell Sci, 24, 217-54.

    Google Scholar 

  31. Davidson RL, Ephrussi RLB and Yamamoto K, 1966, Regulation of pigment synthesis in mammalian cells, as studied by somatic hybridization. Proc Natl Acad Sci USA, 56, 1437-40.

    Google Scholar 

  32. Powers TP and Davidson RL, 1996, Coordinate extinction of melanocyte-specific gene expression in hybrid cells. Som Cell Mol Gen, 22, 41-56.

    Google Scholar 

  33. Gourdeau H and Fournier REK, 1990, Genetic analysis of mammalian cell differentiation. Ann Rev Cell Biol, 6, 69-94.

    Google Scholar 

  34. Powers TP, Shows TB and Davidson RL, 1994, Pigment-cell-specific genes from fibroblasts are transactivated after chromosomal transfer into melanoma cells. Mol Cell Biol, 14, 1179-90.

    Google Scholar 

  35. Darlington GJ, Bernhard HP and Ruddle FH, 1974, Human serum albumin phenotype activation in mouse hepatoma-human leukocyte cell hybrids. Science, 185, 859-62.

    Google Scholar 

  36. Malawista SE and Weiss MC, 1974, Expression of differentiated function in hepatoma cell hybrids: high frequency of induction of mouse albumin production in rat hepatoma-mouse lymphoblast hybrids. Proc Natl Acad Sci USA, 71, 927-31.

    Google Scholar 

  37. Giacomoni D, 1979, Tumorigenicity and intracisternal A-particle expression of hybrids between murine myeloma and lymphocytes. Cancer Res, 39, 4481-4.

    Google Scholar 

  38. Kohler G and Milstein C, 1975, Continuous cultures of fused cells secreting antibody of predefined specificity. Nature, 256, 495-7.

    Google Scholar 

  39. De Baetselier P, Gorelik E, Eshhar Z, et al.1981, Metastatic properties conferred on nonmetastatic tumors by hybridization of spleen B-lymphocytes with plasmacytoma cells. J Natl Cancer Inst, 67, 1079-87.

    Google Scholar 

  40. De Baetselier P, Roos E, Brys L, Remels L and Feldman M, 1984, Generation of invasive and metastatic variants of a non-metastatic T-cell lymphoma by in vivofusion with normal host cells. Int J Cancer, 34, 731-8.

    Google Scholar 

  41. Roos E, La Riviere G, Collard JG, Stukart MJ and De Baetselier P, 1985, Invasiveness of T-cell hybridomas in vitroand their metastatic potential in vivo. Cancer Res, 45, 6238-43.

    Google Scholar 

  42. Collard JG, van de Poll M, Scheffer A, et al.1987, Location of genes involved in invasion and metastasis on human chromosome 7. Cancer Res, 47, 6666-70.

    Google Scholar 

  43. La Riviere G, Schipper CA, Collard JG and Roos E, 1988, Invasiveness in hepatocyte and fibroblast mono-layers and metastatic potential of T-cell hybridomas in mice. Cancer Res, 48, 3405-10.

    Google Scholar 

  44. Lagarde AE, Donaghue TP, Dennis JW and Kerbel RS, 1983, Genotypic and phenotypic evolution of a murine tumor during its progression in vivotoward metastasis. J Natl Cancer Inst, 71, 183-91.

    Google Scholar 

  45. De Baetselier P, Roos E, Brys L, et al. 1984, Non-metastatic tumor cells acquire metastatic properties following somatic hybridization with normal cells. Cancer Metastasis Rev, 3, 5-24.

    Google Scholar 

  46. Larizza L and Schirrmacher V, 1984, Somatic cell fusion as a source of genetic rearrangement leading to metastatic variants. Cancer Metastasis Rev, 3, 193-222.

    Google Scholar 

  47. Lagarde AE and Kerbel RS, 1985, Somatic cell hybridization in vivoand in vitroin relation to the metastatic phenotype. Biochim Biophys Acta, 823, 81-110.

    Google Scholar 

  48. Larizza L, Schirrmacher V and Pfluger E, 1984, Acquisition of high metastatic capacity after in vitrofusion of a non-metastatic tumor line with a bone marrow-derived macrophage. J Exp Med, 160, 1579-84.

    Google Scholar 

  49. Kerbel RS, Lagarde AE, Dennis JW and Donaghue TP, 1983, Spontaneous fusion in vivobetween normal host and tumor cells: possible contribution to tumor progression and metastasis studied with a lectin-resistant mutant tumor. Mol Cell Biol, 3, 523-38.

    Google Scholar 

  50. Larizza L, Schirrmacher V, Graf L, et al.1984, Suggestive evidence that the highly metastatic variant ESb of the T-cell lymphoma Eb is derived from spontaneous fusion with a host macrophage. Int J Cancer, 34, 699-707.

    Google Scholar 

  51. Hu F and Pasztor LM, 1975, In vivohybridization of cultured melanoma cells and isogenic normal mouse cells. Different, 4, 93-7.

    Google Scholar 

  52. Halaban R, Nordlund J, Francke U, Moellmann G and Eisenstadt JM, 1980, Supermelanotic hybrids derived from mouse melanomas and normal mouse cells. Somat Cell Genet, 6, 29-44.

    Google Scholar 

  53. Goldenberg DM, Bhan RD and Pavia RA, 1971, In vivohuman-hamster somatic cell fusion indicated by glucose-6-phosphate dehydrogenase and lactate dehydrogenase profiles. Cancer Res, 31, 1148-52.

    Google Scholar 

  54. Goldenberg DM, Pavia RA and Tsao MC, 1974, In vivohybridization of human tumour and normal hamster cells. Nature, 250, 649-51.

    Google Scholar 

  55. Weiner F, Fenyö EM, Klein G and Harris H, 1972, Fusion of tumour cells with host cells. Nature, 238, 155-9.

    Google Scholar 

  56. Weiner F, Fenyö EM and Klein G, 1974, Tumor-host cells hybrids in radiochimeras. Proc Natl Acad Sci USA, 71, 148-52.

    Google Scholar 

  57. Larizza L, Schirrmacher V, Stöhr M, Pflüger E and Dzarlieva R, 1984a Inheritance of immunogenicity and metastatic potential in murine cell hybrids from the T-lymphoma ESb08 and normal spleen lymphocytes. J Natl Cancer Inst, 72, 1371-81.

    Google Scholar 

  58. Fortuna MB, Dewey MJ and Furmanski P, 1989, Cell fusion in tumor development and progression: Occurrence of cell fusion in primary methylcholanthrene-induced tumorigenesis. Int J Cancer, 44, 731-7.

    Google Scholar 

  59. Fortuna MB, Dewey MJ and Furmanski P, 1990, Enhanced lung colonization and tumorigenicity of fused cells isolated from primary MCA tumors. Cancer Lett, 55, 109-14.

    Google Scholar 

  60. Barski G and Cornefert Fr, 1962, Characteristics of “hybrid”-type clonal cell lines obtained from mixed cultures in vitro. J Natl Cancer Inst, 28, 801-21.

    Google Scholar 

  61. Miller FR, McInerney D, Rogers C and Miller B, 1988, Spontaneous fusion between metastatic mammary tumor subpopulations. J Cell Biochem, 36, 129-36.

    Google Scholar 

  62. Miller FR, Mohamed AN and McEachern, 1989, Production of a more aggressive tumor cell variant by spontaneous fusion of two mouse tumor subpopulations. Cancer Res, 49, 4316-21.

    Google Scholar 

  63. Janzen HW, Millman PA and Thurston OG, 1971, Hybrid cells in solid tumors. Cancer, 27, 455-9.

    Google Scholar 

  64. Hart IR, 1984, Tumor cell hybridization and neoplastic progression. In: Nicolson GL and Milas L, eds. Cancer Invasion and Metastasis: Biologic and Therapeutic Aspects.New York: Raven Press, pp. 133-43.

    Google Scholar 

  65. Aviles D, Jami J, Rousset J-P and Ritz E, 1977, Tumor ×? host cell hybrids in the mouse: chromosomes from the normal cell parent maintained in malignant hybrid tumour. J Natl Cancer Inst, 58, 1391-7.

    Google Scholar 

  66. Pratt NR, Rees RC and Potter CW, 1989, In vivotumour × ?host cell fusion in spontaneous Syrian hamster metastasis. Eur J Cancer Clin Oncol, 25, 1809-16.

    Google Scholar 

  67. Atkin NB, 1979, Premature chromosome condensation in carcinoma of the bladder: presumptive evidence for fusion of normal and malignant cells. Cytogenet Cell Genet, 12, 217-19.

    Google Scholar 

  68. Kovacs G, 1985, Premature chromosome condensation: Evidence for in vivocell fusion in human malignant tumours. Int J Cancer, 36, 637-41.

    Google Scholar 

  69. Kerschmann RL, Woda BA and Majno G, 1995, The fusion of tumor cells with host cells; reflections on an ovarian tumor. Perspect Biol Med, 38, 467-72.

    Google Scholar 

  70. Evans R, 1972, Macrophages in syngeneic animal tumours. Transplant, 14, 468-73.

    Google Scholar 

  71. Gauci CL and Alexander P, 1975, The macrophage content of some human tumors. Cancer Lett, 1, 29-32.

    Google Scholar 

  72. Lagarde AE, 1986, Sporadic somatic fusion between MDAY-D2 murine tumor cells and DBA/2 host cells: Role in metastasis. Int J Cancer, 37, 905-10.

    Google Scholar 

  73. Munzarova M and Kovrik J, 1987, Is cancer a macrophage-mediated autoaggressive disease? Lancet, i, 952-4.

    Google Scholar 

  74. Munzarova M, Lauerova L and Capkova J, 1992, Are advanced malignant melanoma cells hybrids between melanocytes and macrophages? Melanoma Res, 2, 127-9.

    Google Scholar 

  75. Pawelek JM, 1993, Melanoma as a macrophage/melanocyte hybrid and the symbiotic nature of eukaryotic cells. Melanoma Res, 3, 75-6.

    Google Scholar 

  76. Pawelek JM, 1984, In: Barnes DW, Sirbasku DA and Sato GH, eds. Methods for Serum-Free Culture of Neuronal and Lymphoid Cells. New York, NY: Alan R Liss, Inc, pp. 57-66.

    Google Scholar 

  77. Cloudman AM, 1941, The effect of an extra-chromosomal influence upon transplanted spontaneous tumors in mice. Science, 93, 380-1.

    Google Scholar 

  78. Yasamura Y, Tashjian AH, Jr and Sato GH, 1966, Establishment of four functional, clonal strains of animal cells in culture. Science, 154, 1186-8.

    Google Scholar 

  79. Pawelek J, Halaban R and Christie G, 1975, Melanoma cells which require cyclic AMP for growth. Nature, 258, 539-40.

    Google Scholar 

  80. Szybalski W, Szylbalska EH and Ragni B, 1962, Genetic studies with human cell lines. Natl Cancer Inst Monograph, 7, 75-89.

    Google Scholar 

  81. Littlefield JW, 1966, The use of drug-resistant markers to study the hybridization of mouse fibroblasts. Exp Cell Res, 41, 190-6.

    Google Scholar 

  82. Purpura DP and Baker HJ, 1977, Antibodies to major histocompatibility antigens produced by hybrid cell lines. Nature, 266, 550-4.

    Google Scholar 

  83. Tautz D, 1989, Hypervariability of simple sequences as a general source for polymorphic DNA markers. Nucleic Acids Res, 17, 6463-71.

    Google Scholar 

  84. Serikawa T, Kuramoto T, Hilbert P, et al. 1992, Rat gene mapping using PCR-analyzed microsatellites. Genetics, 131, 701-21.

    Google Scholar 

  85. Love JM, Knight AM, McAleer MA and Todd JA, 1990, Towards construction of a high resolution map of the mouse genome using PCR-analysed microsatellites. Nucleic Acids Res, 18, 4123-30.

    Google Scholar 

  86. Hitomi Y, Yamada T and Oikawa T, 1993, Extinction of expression of the PU1/Sfpi-1 putative oncogene encoding a B-cell and macrophage-specific transcription factor in somatic cell hybrids. Cancer Res, 53, 5759-65.

    Google Scholar 

  87. Bishop CE and Hatar D, 1987, Molecular cloning and sequence analysis of a mouse Y chromosome RNA transcript expressed in the testis. Nucleic Acids Res, 152959-69.

    Google Scholar 

  88. Albini A, Iwamoto Y, Kleinman HK, et al. 1987, A rapid in vitroassay for quantitating the invasive potential of tumor cells. Cancer Res, 47, 3239-45.

    Google Scholar 

  89. Sodi SA, Chakraborty AK, Avissar YJ, et al. 1996, Co-expression of differentiated functions in highly metastatic melanoma/macrophage fusion hybrids. J Pig Cell Res Suppl, 5, 51.

    Google Scholar 

  90. Rachkovsky M, Sodi S, Chakraborty A and Pawelek J, 1996, Metastatic potential in mice vs motility and biomatrix crossing in vitroby melanoma × ?macrophage hybrids. J Pig Cell Res Suppl, 5, 50.

    Google Scholar 

  91. Kerbel RS, Twiddy RR and Robertson DM, 1978, Induction of a tumor with greatly increased metastatic growth potential by injection of cells from a low-metastatic H-2 heterozygous tumor cell line into an H-2 incompatible parental strain. Int J Cancer, 22, 583-94.

    Google Scholar 

  92. De Baetselier P, Roos E, van Hecke D, et al.1988, Syngeneic in vivopassage of the murine BW 5147 lymphoma results in the expression of a stable metastatic phenotype. Int J Cancer, 41, 720-6.

    Google Scholar 

  93. Kerbel RS, Waghorne C, Man MS, Elliott B and Breitman ML, 1987, Alteration of the tumorigenic and metastatic properties of neoplastic cells is associated with the process of calcium phosphate-mediated DNA transfection. Proc Natl Acad Sci USA, 84, 1263-7.

    Google Scholar 

  94. MacDougall JR, Bani MR, Lin Y, Rak J and Kerbel RS, 1995, The 92 kDa gelatinase B is expressed by advanced stage melanoma cells: suppression by somatic cell hybridization with early stage melanoma cells. Cancer Res, 55, 4174-81.

    Google Scholar 

  95. Wakeling WF, Greetham J, Devlin LM and Bennett DC, 1992, Suppression of properties associated with malignancy in murine melanoma-melanocyte hybrid cells. Br J Cancer, 65, 529-37.

    Google Scholar 

  96. Clark WH Jr, Mastrangelo MJ, Ainsworth AM, et al.1977, Current concepts of the biology of human cutaneous malignant melanoma. Adv Cancer Res, 24, 267-338.

    Google Scholar 

  97. Ruff MR and Pert DB, 1984, Small cell carcinoma of the lung: macrophage-specific antigens suggest hemopoietic stem cell origin. Science, 225, 1034-6.

    Google Scholar 

  98. Jain RK, 1994, Barriers to drug delivery in solid tumors. Sci Amer, 271, 58-65.

    Google Scholar 

  99. Graeber TG, Osmanian C, Jacks T, et al. 1996, Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature, 379, 88-91.

    Google Scholar 

  100. Savill J, Fadok V, Henson P and Haslett C, 1993, Phagocyte recognition of cells undergoing apoptosis. Immunol Today, 14, 131-6.

    Google Scholar 

  101. Most J, Spotl L, Mayr G, Sarti A and Dierich MP, 1997, Formation of multinucleated giant cells in vitrois dependent on the stage of monocyte to macrophage maturation. Blood, 89, 662-671.

    Google Scholar 

  102. Margulis L and Sagan D, 1986, Cannibalism and other mergers. In: Origins of Sex. New Haven, CT: Yale University Press, pp. 146-52.

    Google Scholar 

  103. Wakeling WF, Greetham J and Bennett DC, 1994, Efficient spontaneous fusion between some co-cultured cells, especially murine melanoma cells. Cell Biol Int, 18, 207-10.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rachkovsky, M., Sodi, S., Chakraborty, A. et al. Melanoma × macrophage hybrids with enhanced metastatic potential. Clin Exp Metastasis 16, 299–312 (1998). https://doi.org/10.1023/A:1006557228604

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006557228604

Navigation